Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | US

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
TRAJANO Provides strategic consulting and innovative business solutions.	Spain	YTRA
Transgene Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.	France	TNG
TRANS GENIC GROUP INC. Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.	Japan	2342
Trevi Therapeutics, Inc. Clinical-stage biopharma developing an oral therapy for chronic cough in IPF and RCC.	United States of America	TRVI
TrueBlue, Inc. Provides staffing, recruitment, and workforce solutions for businesses in diverse sectors.	United States of America	TBI
True Data Inc. A big data platform offering consumer purchasing analytics from Japan's largest ID-POS data network.	Japan	4416
Tsubota Laboratory Incorporated Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.	Japan	4890
TWOSTONE&Sons Inc. An engineer platform providing IT talent and marketing services for corporate digital transformation.	Japan	7352
UJU Holding Limited AI-driven, full-link short-video marketing solutions for enterprises in China.	Hong Kong	1948
unerry,Inc. Transforms location data into actionable insights for retail and public sectors using AI.	Japan	5034